The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.
Bridges the 'pharmaverse' clinical reporting stack and the R4SUB (Ready for Submission) ecosystem. Converts 'metacore' metadata objects and ADaM (Analysis Data Model) datasets - such as those built with 'admiral' - into standardized R4SUB evidence table rows via 'r4subcore', so that submission readiness can be scored with 'r4subscore' without changing an existing pharmaverse pipeline.
| Version: | 0.1.0 |
| Depends: | R (≥ 4.2) |
| Imports: | cli, r4subcore, tibble |
| Suggests: | knitr, metacore, pharmaverseadam, r4subdata, r4subprofile, r4subscore, rmarkdown, testthat (≥ 3.0.0) |
| Published: | 2026-09-11 |
| DOI: | 10.32614/CRAN.package.r4subpharma (may not be active yet) |
| Author: | Pawan Rama Mali |
| Maintainer: | Pawan Rama Mali <prm at outlook.in> |
| BugReports: | https://github.com/R4SUB/r4subpharma/issues |
| License: | MIT + file LICENSE |
| URL: | https://r4sub.github.io/r4subpharma/, https://github.com/R4SUB/r4subpharma |
| NeedsCompilation: | no |
| Materials: | README, NEWS |
| CRAN checks: | r4subpharma results |
| Reference manual: | r4subpharma.html , r4subpharma.pdf |
| Vignettes: |
Case study: scoring the CDISC pilot ADaM package (source, R code) Scoring submission readiness from a pharmaverse pipeline (source, R code) |
| Package source: | r4subpharma_0.1.0.tar.gz |
| Windows binaries: | r-devel: not available, r-release: not available, r-oldrel: r4subpharma_0.1.0.zip |
| macOS binaries: | r-release (arm64): not available, r-oldrel (arm64): r4subpharma_0.1.0.tgz, r-release (x86_64): r4subpharma_0.1.0.tgz, r-oldrel (x86_64): r4subpharma_0.1.0.tgz |
Please use the canonical form https://CRAN.R-project.org/package=r4subpharma to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.